Clinical outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome
CONCLUSION: Patients with MF/SS do not necessarily have worse COVID-19 outcomes compared to the general population.PMID:37517402 | DOI:10.1159/000531831 (Source: Acta Haematologica)
Source: Acta Haematologica - July 30, 2023 Category: Hematology Authors: Ilana Levy Yurkovski Lior Rokach Guy Melamed Hillel Alapi Sivan Gazit Tal Patalon Tamar Tadmor Source Type: research
Immune dysfunction and infection - interaction between CLL and treatment A reflection on current treatment paradigms and unmet needs
Acta Haematol. 2023 Jul 27. doi: 10.1159/000533234. Online ahead of print.ABSTRACTBackground Chronic lymphocytic leukemia (CLL) is a hematological malignancy characterized by immune dysfunction, which significantly contributes to increased morbidity and mortality due to infections. Summary Advancement in therapeutic strategies based on combination chemoimmunotherapy and targeted treatment have increased life expectancy for patients affected by CLL. However, mortality and morbidity due to infection showed no improvement over the last decades. Although therapy options are highly efficient in targeting leukemic cells, several...
Source: Acta Haematologica - July 27, 2023 Category: Hematology Authors: Ernesto Gargiulo Rebecca Svanberg Teglgaard Tereza Faitov á Carsten Utoft Niemann Source Type: research
Erratum
Acta Haematol. 2023;146(2):172. doi: 10.1159/000529163. Epub 2023 Jan 24.NO ABSTRACTPMID:37497945 | DOI:10.1159/000529163 (Source: Acta Haematologica)
Source: Acta Haematologica - July 27, 2023 Category: Hematology Source Type: research
Immune dysfunction and infection - interaction between CLL and treatment A reflection on current treatment paradigms and unmet needs
Acta Haematol. 2023 Jul 27. doi: 10.1159/000533234. Online ahead of print.ABSTRACTBackground Chronic lymphocytic leukemia (CLL) is a hematological malignancy characterized by immune dysfunction, which significantly contributes to increased morbidity and mortality due to infections. Summary Advancement in therapeutic strategies based on combination chemoimmunotherapy and targeted treatment have increased life expectancy for patients affected by CLL. However, mortality and morbidity due to infection showed no improvement over the last decades. Although therapy options are highly efficient in targeting leukemic cells, several...
Source: Acta Haematologica - July 27, 2023 Category: Hematology Authors: Ernesto Gargiulo Rebecca Svanberg Teglgaard Tereza Faitov á Carsten Utoft Niemann Source Type: research
Erratum
Acta Haematol. 2023;146(2):172. doi: 10.1159/000529163. Epub 2023 Jan 24.NO ABSTRACTPMID:37497945 | DOI:10.1159/000529163 (Source: Acta Haematologica)
Source: Acta Haematologica - July 27, 2023 Category: Hematology Source Type: research
